MiR‐195‐5p could dramatically increase chemosensitivity in 5‐FU‐resistant HCT116/5‐FU and SW480/5‐FU CRC cell lines by reducing the expression of glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) that is involved in the process of choline phospholipid metabolism.63 The gene discussed is GDPD5; the disease is colorectal carcinoma.